Manish Kohli, MD

Articles by Manish Kohli, MD

Dr. Kohli on the Use of Enzalutamide and Apalutamide in mHSPC

May 19th 2020

Manish Kohli, MD, discusses the use of enzalutamide (Xtandi) and apalutamide (Erleada) in patients with metastatic hormone-sensitive prostate cancer (mHSPC).

Dr. Kohli on the Use of Enzalutamide and Apalutamide in mHSPC

ByManish Kohli, MD

May 18th 2020

Manish Kohli, MD, discusses the use of enzalutamide (Xtandi) and apalutamide (Erleada) in patients with metastatic hormone-sensitive prostate cancer (mHSPC).

Dr. Kohli on Drugs That Have Been Evaluated in mCRPC

ByManish Kohli, MD

January 25th 2020

Manish Kohli, MD, discusses drugs that have been evaluated in metastatic castration-resistant prostate cancer.

Dr. Kohli on the Challenges of Molecular Classification in Prostate Cancer

ByManish Kohli, MD

September 25th 2019

Manish Kohli, MD, discusses the challenges of molecular classification in prostate cancer.

Dr. Kohli Discusses Ongoing Correlative Science in Prostate Cancer

ByManish Kohli, MD

September 11th 2019

Manish Kohli, MD, vice chair, Department of Genitourinary Oncology, Moffitt Cancer Center, discusses ongoing research with correlative sciences in prostate cancer.

Dr. Kohli on Sequencing Concerns in Metastatic Hormone-Sensitive Prostate Cancer

ByManish Kohli, MD

September 4th 2019

Manish Kohli, MD, vice chair, Department of Genitourinary Oncology, Moffitt Cancer Center, discusses sequencing concerns in metastatic hormone-sensitive prostate cancer (mHSPC).